Sekretessinställningar
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Aktiemarknader
    • BörsRealtidskurser, index och marknadsutveckling
    • MorgonrapportDaglig marknadssammanfattning och nattens viktigaste händelser
    • BörskalenderKommande resultat, noteringar och företagshändelser
    • UtdelningskalenderKommande och tidigare utdelningar
  • Bolag
    • BolagBläddra och filtrera hela listan över noterade bolag
    • UpptäckInspiration till din nästa investering
    • BörsnoteringarNya noteringar och kommande börsintroduktioner
    • ÅrsstämmorDatum för årsstämmor och aktieägarinformation
  • Aktieforskning
    • AktieanalysExpertaktieanalys och rekommendationer
    • ArtiklarNyheter, insikter och marknadskommentarer
    • PortföljInderes modellportfölj
    • inderesTVVideohub för aktieanalys, forskning och expertkommentarer
    • TranskriptionerFullständiga utskrifter av resultatsamtal och investerarmöten
    • AktiejämförelseJämför nyckeltal och utveckling för flera aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • BlankningSe vilka börsnoterade bolag som har offentliggjorda korta positioner
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Q&A
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer

Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

Nomination Committee appointed ahead of Getinge's Annual General Meeting 2027

GETI BRegulatoriskt pressmeddelande2026-10-15 09:00
Ladda ner börsmeddelandet

The members of the Nomination Committee for Getinge AB's Annual General Meeting 2027 have now been appointed.

In accordance with the principles adopted at the 2020 Annual General Meeting, the Nomination Committee ahead of the Annual General Meeting shall consist of members appointed by the four largest shareholders in terms of voting rights as of August 31 each year, as well as the Chairman of the Board.

Getinge's Nomination Committee ahead of the Annual General Meeting 2027 has now been appointed and consists of the company's Chairman of the Board, Johan Malmquist, and representatives appointed by the following shareholders, in order of voting power:

  • Carl Bennet, Carl Bennet AB, Chairman of the Nomination Committee
  • Sophie Larsén, AMF Pension & Fonder
  • Anna Magnusson, Fourth Swedish National Pension Fund
  • Anna Strömberg, Carnegie Fonder

The task of the Nomination Committee is to prepare proposals for the 2027 Annual General Meeting regarding the Chairman of the Meeting, the number of Board members, the remuneration to each of the Board members, the election of the Board of Directors and the Chairman of the Board, the remuneration to the auditor and the election of the auditor, as well as, to the extent deemed necessary, proposals for changes to the Nomination Committee's instructions.

Shareholders who wish to submit proposals to the Nomination Committee can contact the Nomination Committee by e-mail at valberedningen@getinge.com or by mail to the following address:

Getinge AB (publ)
Att: Valberedningen
Box 8861
SE-402 72 Göteborg
SWEDEN

Proposals must be received by the Nomination Committee no later than January 15, 2027, in order to ensure that they are addressed by the Committee.

For more information, please contact:
David Kördel, Head of Investor Relations
Phone: +46 (0)10 335 0077
E-mail:
david.kordel@getinge.com


About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.